3Wang HH, Liu M, Clegg DJ, etal. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation [J]. Biochim Biophys Acta, 2009; 1791(11):1037- 1047.
4Zanlungo S, Rigotti A. Determinants of transhepatic cholesterol flux and their relevance for gallstone formation [J]. Liver Int, 2009.29(3): 323-330.
5Kovar J, Suchanek P, Hubacek JA, et al. The A-204C polymorphism in the cholesterol 7α-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet [J]. Physiol Res, 2004; 53(5): 565-568.
6Kajinaml K, Brousseau ME, Ordovas JM, etal. Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDL cholesterol lowering response to atorvastatin [J]. Atherosclerosis, 2004. 175(2): 287-293.
7Gilardi F, Mitro N, Godio C, et al . The pharmacological exploitation of cholesterol 7α-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to ehromatln remodelling to reduce plasma cholesterol [J]. Pharmacol Ther, 2007; 116(3) : 449-472.
8Nakeeb A, Comuzzie AG, Martin L, et al. Gallstones: genetics versus environment [J]. Ann Surg, 2002; 235 (6): 842-849.
9Wang HH, Portincasa P, Mendez Sanchez N, etal. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones[J]. Gastroenterology, 2008; 134(7): 2101-2110.
10Kouii K, Margaret E, Brousseau, et al. A promoter poly morphism in cholesterol 7α- hydroxylase interacts with apoli poprotein E genotype in the LDL- lowering response to atorv astatin [J]. Atherosclerosis, 2005,180(3): 407- 415.
